机构:[1]Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.[3]Department of Pathology, Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, China.[4]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.广东省中医院深圳市中医院深圳医学信息中心[5]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.
第一作者机构:[1]Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.[3]Department of Pathology, Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.[3]Department of Pathology, Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, China.[5]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.
推荐引用方式(GB/T 7714):
Qiu Junfeng,Li Mingzhou,Su Cailin,et al.FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer[J].FRONTIERS IN ONCOLOGY.2022,12:doi:10.3389/fonc.2022.894043.
APA:
Qiu Junfeng,Li Mingzhou,Su Cailin,Liang Yihao,Ou Ruizhang...&Zhang Chao.(2022).FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer.FRONTIERS IN ONCOLOGY,12,
MLA:
Qiu Junfeng,et al."FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer".FRONTIERS IN ONCOLOGY 12.(2022)